-
PSNI will not be able to offer the option to pay retention fees in instalments this retention year
Sun 12th May 2024
Despite agreeing to offer pharmacists in Northern Ireland the option to pay their retention fees in quarterly direct debit payments from June 2024, the Pharmaceutical Society of Northern Ireland (PSNI) has had to delay this intention due to the need for legislative amendment.
-
RPS National Pharmacy Boards Elections 2024 – England
Thu 9th May 2024
The PDA has offered candidates of the Royal Pharmaceutical Society (RPS) National Board Elections 2024 in England the opportunity to tell PDA members their views on key issues.
-
PDA to attend 13th annual STUC LGBT+ Workers’ Conference
Wed 8th May 2024
The Scottish Trades Union Congress (STUC) LGBT+ Workers’ Conference will be taking place in Glasgow this week (11-12 May). Previous STUC Equality Award winner and co-opted member of the PDA LGBT+ Committee, Soh Xi Ken will be representing the PDA at the conference.
-
PDA supports a wider healthcare role for pharmacists
Wed 8th May 2024
The PDA has partnered with Aston University and the Priory Community Pharmacy to showcase the opportunities for pharmacists to deliver wider healthcare services as part of vaccination programmes.
-
Joint statement – Boots and the PDA (7 February 2024)
Tue 7th May 2024
The PDA Union and Boots have released their latest joint statement following their Joint Consultative Committee (JCC) meeting, which was held on 7 February 2024.
-
PDA publishes summary of the Pharmacy Technicians Report
Sun 5th May 2024
The PDA has launched its summary of the PDA Pharmacy Technicians Report for members. The summary outlines the key points and recommendations made in 2019.
-
Claire Ward is the first Mayor of the East Midlands
Fri 3rd May 2024
PDA Director of Public Affairs, Claire Ward, has become the first person to serve as Regional Mayor for the East Midlands.
-
PDA cannot support DiCE best practice guidance for online prescribing of GLP-1 receptor agonists for weight management in adults
Fri 3rd May 2024
The PDA is unable to recommend reliance upon the guidance published by the Digital Clinical Excellence (DiCE) as it conflicts with an expert report commissioned by the General Pharmaceutical Council (GPhC). The report is currently being used to prosecute significant numbers of pharmacist prescribers who use a questionnaire-based model of consultation.
-
PDA condemns the government’s increase of prescription charges in England
Wed 1st May 2024
The PDA is opposed to the decision to increase prescription charges from £9.65 to £9.90 per item with effect from 1 May 2024.
-
Insight Online – April 2024
Mon 29th April 2024
This month, learn about how we are defending our members by fighting the discrimination they face and how the Pharmacy First thresholds are adding pressure on pharmacists. Plus, read about some useful resources that will support you in your career!